Skip to main content
. 2018 May 1;9(33):23289–23305. doi: 10.18632/oncotarget.25289

Figure 4. Anti-STn ADC decreases cell viability in vitro.

Figure 4

The indicated cell lines were treated in quadruplicate with increasing concentrations of S3F-CL-MMAE for either 72 (A) or 144 hours (B). The effect of S3F-CL-MMAE on metabolic activity was determined by MTT assay and assessed relative to the untreated control. Error bars represent the SEM. *p <0.05. All experiments were repeated four times.